Abstract
Oxygen is often viewed as being synonymous with life. It is necessary for the living processes of mammals including humans. The arrest of breathing, apart from termination of other functions, is an evident sign of mammalian death. However, soon after death, the body begins to re-utilize oxygen and in a short period it consumes oxygen at much higher rate than in normal life processes. But this process no longer represents controlled biological oxidation. Rather it is uncontrolled autooxidation, peroxidation or free radical oxidation of polyunsaturated lipids. In recent years, interest has grown in the possible links between drug metabolic reactions and certain aspects of lipid biochemistry. Attention has been focused particularly on oxidative processes, namely those of lipid peroxidation and co-oxidation. Lipid peroxidation is now recognized as an important mediator of toxicity.1 Reactive oxygen species (Superoxide anion radical, hydroxyl radical, singlet oxygen and hydrogen peroxide) are produced during enzymatic oxidation of xenobiotics by cytochrome P-450 and other oxidoreductase systems.2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. S. Bus and J. E. Gibson, Lipid peroxidation and its role in toxicology, Rev. Biochem. Toxicol. 1:125 (1979).
H. Kappus, Overview of enzyme systems involved in bioreduction of drugs and in redox cycling, Biochem. Pharmac. 35:1 (1986).
R. W. Estabrook, N. Chacos, C. Martin-Wixtrom, and J. Capdevila, Cytochrome P-450: A versatile vehicle of variable veracity, in Oxygenases and Oxygen Metabolism, M. Nozaki, S. Yamamoto, Y. Ishimura, M. J. Coon, L. Emster, R. W. Estabrook (eds.), Academic Press, New York (1982).
T. L. Dormandy, Free-radical oxidation and antioxidants, Lancet 647 (1978).
L. Masotti, E. Casali and T. Galeotti, Lipid peroxidation in tumor cells,Free Radical Biol. Med. 4:377 (1988).
P. A. Cerutti, Prooxidant states and tumor promotion, Science 227:375 (1985).
P. A. Cerutti, Repairable damage in DNA, in DNA Repair Mechanisms,P. Phanawalt, E. Friedberg, C. Fox (eds.), Academic Press, New York (1978).
K. Brown and I. Fridovich, Superoxide radical and Superoxide dismutase: Threat and defense, Acta Physiol. Scand. Suppl. 492:9 (1980).
I. Emerit, M. Keck, A. Levy, J. Feingold and A. M. Michelson, Activated oxygen species at the origin of chromosome breakage and sister-chromatid exchanges, Mutat. Res. 103:165 (1982).
I. Emerit, A. Levy and P. A. Cerutti, Suppression of tumor promoter phorbol-myristate-acetate induced chromosome breakage by antioxidants and inhibitors of arachidonic acid metabolism, Mutat. Res. 110:327 (1983).
L. Gianni, B. J. Corden and C. E. Meyers, The biochemical basis of anthracycline toxicity and antitumor action, in Reviews in Biochemical Toxicology, Vol. 5, E. Hodson, J. R. Bend and R. M. Philpot (eds.), Elsevier, Amsterdam (1983).
J. W. Lown, H-H. Chen, J. A. Plambeck and E. M. Acton, Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects, Biochem. Pharmacol. 31:575 (1982).
B. Chance, H. Sies and A. Boveris, Hydroperoxide metabolism in mammalian organs, Physiol. Rev. 59:527 (1979).
J. F. Mead, Free radical mechanism of lipid damage and consequences for cellular membranes, in Free Radicals in Biology, W. A. Pryor (ed.), Academic Press, New York (1976).
K. Reszka, P. Kolodziejczyk and J. W. Lown, Horseradish peroxidase-catalyzed oxidation of mitoxantrone, Spectrophotometric and electron paramagnetic resonance studies, J. Free Rad. Biol. Med. 2:25 (1986).
P. Kolodziejczyk, K. Reszka and J. W. Lown, Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone, Free Radical Biol. Med. 5:13 (1988).
P. Kolodziejczyk, K. Reszka and J. W. Lown, Oxidative activation of 5-iminodaunorubicin; action of horseradish peroxidase, Spectroscopic and electron paramagnetic resonance studies, Biochem. Pharmacol. in press (1989).
E. D. Kharash and R. F. Novak, Structural and mechanistic differences in quinone inhibition of microsomal drug metabolism; inhibition of NADPH-cytochrome P-450 reductase activity in cytochrome P-450, Developments in Biochemistry 23:623 (1983).
J. Basra, C. R. Wolf, J. R. Brown and L. H. Patterson, Evidence for human liver mediated Free radical formation by doxorubicin and mitoxantrone, Anticancer Drug Design 1:45(1985).
P. Kolodziejczyk, K. Reszka and J. W. Lown, Alternative to the bioreductive activation of anthracyclines: Enzymatic oxidative metabolism of anthracenediones, 5-iminodaunorubicin and anthrapyrazoles, in Oxy-radicals in Molecular Biology and Pathology, Vol. 82, P. A. Cerutti, I. Fridovich, J. M. McCord (eds.), A. R. Liss, New York (1988).
B. Meunier, Horseradish peroxidase: A useful tool for modeling the extrahepatic biooxidation of exogens, Biochimie 69:3 (1987).
P. Frank and R. F. Novak, Effects of anthrapyrazole antineoplastic agents on lipid peroxidation, Biochem. Biophys. Res. Commun. 140:797 (1986).
B. Testa and P. Jenner, Inhibitors of cytochrome P-450s and their mechanism of action, Drug Metabolism Reviews 12:1 (1981).
R. A. Neal, T. Sawahata, J. Halpert and T. Kamataki, Chemically reactive metabolites as suicide enzyme inhibitors, Drug Metabolism Reviews 14:49 (1983).
R. K. Boutwell, Retinoids and prostaglandin synthesis inhibitors as protective agents against chemical carcinogenesis and tumor promotion, in Radioprotectors and Anticarcinogens, O. F. Nygaard, M. G. Simic (eds.), Academic Press, New York (1983).
J. M. McCord, Superoxide radical: A likely link between reperfusion injury and inflammation, Adv. Free Rad. Biol. Med. 2:325 (1986).
M. J. Waring, Overview of the interaction between chemotherapeutic agents and DNA, Drugs Exptl. Clin. Res. 12:441 (1986).
W. E. M. Lands, Interactions of lipid hydroperoxides with eicosanoid biosynthesis, J. Free Rad. Biol. Med. 1:97 (1985).
K. V. Honn, R. S. Bockman and L. J. Marnett, Prostaglandins and cancer: A review of tumor initiation through tumor metastasis, Prostaglandins 21:833 (1983).
A. Aitokallio-Tallbert, J. Karkkainen, P. Pantzar, T. Wahlstrom, and O. Ylikorkala, Prostaglandin and thromboxane in breast cancer: Relationship between steroid receptor status and medroxyprogesterone-acetate, Br. J. Cancer 5:671 (1985).
A. M. Aitokallio-Tallberg, L. V. Viinikka and R. O. Ylikorkala, Increased synthesis of prostacyclin and thromboxane in human ovarian malignancy, Cancer Res. 48:23968 (1988).
R. W. Egan, P. H. Gale, G. C. Beveridge, L. J. Marnett and F. A. Keuhl, Direct and indirect involvement of radical scavengers during prostaglandin biosynthesis, Adv. Prostaglandin Thromboxane Res. 6:153 (1980).
J. Capdevila, R. W. Estabrook and R. A. Prough, Differences in the mechanism of NADPH and cumene hydroperoxide-supported reactions of cytochrome P-450, Arch. Biochem. Biophys. 200:186 (1980).
E. L. Wheeler, Cytochrome P-450 mediated interaction between hydroperoxide and molecular oxygen, Biochem. Biophys. Res. Commun. 110:646 (1983).
J. C. Sircar, C. F. Schwender and E. A. Johnson, Soybean lipoxygenase inhibition by nonsteroidal antiinflammatory drugs, Prostaglandins 25:393 (1983).
R. H. Tullman and R. P. Hanzlik, Inactivation of cytochrome P-450 and monoamine oxidase by cyclopropylamines, Drug Metabolism Review 15:11632 (1984).
C. Baarnhielm and G. Hansson, Oxidation of 1,4-dihydropyridines by prostaglandin synthase and the peroxic function of cytochrome P-450, Demonstration of a free radical intermediate, Biochem. Pharmacol. 35:14195 (1986).
R. F. Novak, E. D. Kharasch, P. Frank and M. Runge-Morris, Anthracyclines, anthracenediones and anthrapyrazoles: Comparison of redox cycling activity and effects on lipid peroxidation and prostaglandin production, in Anthracycline and Anthracenedione Anticancer Agents, J. W. Lown (ed.), Elsevier, Amsterdam (1989).
P. Lesca, P. Lecointe, C. Paoletti and D. Mansuy, Ellipticines as potent inhibitors of drug metabolism: Protective effect against chemical mutagenesis and carcinogenesis, Biochemie 60:1011 (1978).
L. Levine, Arachidonic acid transformation and tumor production, Adv. Cancer Res. 35:49(1981).
E. Carafoli, Intracellular calcium homeostasis, Annu. Rev. Biochem. 56:395 (1987).
C. Richter and B. Frei, Ca2+ release from mitochondria induced by prooxidants, Free Rad. Biol. Med. 4:365 (1988).
C. Richter, B. Frei and P. A. Cerutti, Mobilization of mitochondrial Ca2+ by hydroperoxyeicosatetraenoic acid, Biochem. Biophys. Res. Commun. 143:609 (1987).
N. Yamanaka, T. Kato, K. Nishida, T. Fujikawa, M. Fukushima and K. Ota, Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by d,I-alpha tocopherol acetate or coenzyme Q10 in mouse, Cancer Chemother. Pharmacol. 3:223 (1979).
H. M. Olson and C. C. Capen, Chronic cardiotoxicity of doxorubicin (adriamycin) in the rat: Morphologic and biochemical investigations, Toxicol. Appl. Pharmacol. 44:605 (1978).
M. Moore, H. Thor, G. Moore, S. Nelson, P. Moldeus and S. Orrenius, The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+, J. Biol. Chem. 24:13035 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Kolodziejczyk, P., Lown, J.W. (1990). Peroxidase Induced Metabolism and Lipid Peroxide Scavenging by Antitumor Agents. In: Emerit, I., Packer, L., Auclair, C. (eds) Antioxidants in Therapy and Preventive Medicine. Advances in Experimental Medicine and Biology, vol 264. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5730-8_51
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5730-8_51
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5732-2
Online ISBN: 978-1-4684-5730-8
eBook Packages: Springer Book Archive